<DOC>
	<DOCNO>NCT02439372</DOCNO>
	<brief_summary>Consequences latent cytomegalovirus ( CMV ) infection reactivation ulcerative colitis flare , flare-worsening factor simple bystander , debate . Theoretically , CMV-specific cell-mediate immune response categorize patient high low risk CMV colitis . The investigator thus evaluate usefulness CMV-specific ELISPOT assay patient ulcerative colitis flare assess impact CMV colitis ulcerative colitis flare .</brief_summary>
	<brief_title>Assessment CMV-specific ELISPOT Assay Predicting CMV Colitis Patient With Ulcerative Colitis</brief_title>
	<detailed_description>Moderate severe ulcerative colitis patient admit Inflammatory Bowel Disease ( IBD ) center enrol study . Eligible patient active UC Mayo score 6-12 point ( moderate severe disease activity ) . The investigator evaluate whether CMV-specific cell-mediated immune response admission predict risk active cytomegalovirus infection ( true pathogen versus bystander ) .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<criteria>moderate severe UC require hospitalization age 18 agree write informed consent pregnancy foreign immunosuppressed patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>